During the past decade, American Institute of Research conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 34 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 18 clinical trials were completed. i.e. 105.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "American Institute of Research" #1 sponsor was "Pfizer" with 12 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "AstraZeneca" with 2 trials sponsored, "BioAtla, Inc." with 2 trials sponsored and "Helsinn Healthcare SA" with 2 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "American Institute of Research" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Parexel" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bionomics Limited" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "American Institute of Research" are "Non Small Cell Lung Cancer" (3 trials), "Renal Cell Carcinoma" (3 trials), "Breast Cancer" (2 trials), "Cardiovascular Disease" (2 trials) and "Chemotherapy-Induced Nausea and Vomiting" (2 trials). Many other conditions were trialed in "American Institute of Research" in a lesser frequency.

Most popular intervention types in "American Institute of Research" are "Drug" (48 trials), "Biological" (12 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Epoetin Hospira" (4 trials), "Dapagliflozin" (2 trials), "Dexamethasone" (2 trials) and "Netupitant and Palonosetron" (2 trials). Other intervention names were less common.

The vast majority of trials in "American Institute of Research" are 55 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "American Institute of Research". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in American Institute of Research, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in American Institute of Research, 6 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".